IPO to open on April 3 and to close on April 05, 2019
Metropolis Healthcare, a leading diagnostics companies in India, proposes to open its initial public offering (IPO) of equity shares on April 03, 2019.
The IPO consists of 13,685,095 equity shares of face value of Rs 2 each (equity shares) consisting of an offer for sale of up to 6,272,335 equity shares by Dr Sushil Kanubhai Shah (the Promoter Selling Shareholder) and up to 7,412,760 equity shares by CA Lotus Investments (the Investor Selling Shareholder) (the Offer). The offer includes a reservation of up to 300,000 equity shares, for subscription by eligible employees (the Employee Reservation Portion). The offer less the Employee Reservation Portion is hereinafter referred to as the ‘Net Offer’, and such Net Offer aggregates up to 13,385,095 equity shares.
The bid/offer closing date is on april 05, 2019. the price band for the offer is from Rs 877 to Rs 880 per equity share. Bids can be made for a minimum lot of 17 equity shares and in multiples of 17 equity shares thereafter.
The equity shares are proposed to be listed on BSE and NSE.
The Book Running Lead Managers (BRLMs) to the offer are JM Financial, Credit Suisse Securities (India), Goldman Sachs (India) Securities, HDFC Bank and Kotak Mahindra Capital Company.